Xarelto (also known as rivaroxaban) is a newer blood thinning medication that was approved in 2011 for consumer use. It was manufactured by the pharmaceutical company Bayer and then marketed locally by Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson). While it had promising results, there was one dangerous side effect: those that take it could suffer from uncontrollable, life-threatening bleeding.
What is the Lawsuit?
Those that took Xarelto quickly found that this drug did not have an antidote and patients prescribed the medication were not properly informed of the medication’s severe risk. The lawsuit was designed to hold the drug manufacturer responsible for the dangerous side effects and for their inability to notify the public properly.
The drug has been linked to an increased number of uncontrollable bleeding episodes, but unlike warfarin that has an antidote, there is little physicians can do to stop Xarelto. This means that even a minor injury could become life threatening for those that take this blood thinning medication.
Other injuries that have been associated with Xarelto include:
- Retinal hemorrhages
- Intracranial bruises and bleeding
- Hemoglobin decreases
- Gastrointestinal bleeding
A warning letter was issued by the FDA in 2013, noting that the advertisement for the drug minimized these very serious risks. Also, the FDA warned physicians and the company itself that the company’s advertisements blatantly made it seem as though the risks of the drug were not important – and very unlikely to occur. The agency also noted that the biggest concern with the drug was uncontrollable bleeding.
Multidistrict Litigation Has Begun
Attorneys are involved in a complex multidistrict litigation regarding Xarelto. These suits include multiple trials and offer more benefits than traditional class-action lawsuits because they are efficient and address the individual needs of victims rather than just grouping them together in a single class.
The Statute of Limitations
Just like other lawsuits, there is a statute of limitations that applies to the Xarelto lawsuit. The statute requires that victims of the drug bring their suit to court within a short time after the injury – otherwise they forfeit their right to collect compensation.
Hiring an Attorney for the Xarelto Lawsuit
At Herman, Herman & Katz, LLC, our attorneys will work with you on a contingency fee basis. That means you only pay our law firm if we successfully win your Xarelto case. We have handled several lawsuits regarding the blood thinning medication and can help you as well.
To get started, contact us for a free case review at 844-339-2884 or fill out an online contact form regarding your questions about the Xarelto class action suit.